AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Naltrexone injectable (Vivitrol) approved for opioid dependence.(From the FDA)(Brief article)

Brown University Psychopharmacology Update

| December 01, 2010 | COPYRIGHT 2008 Wiley Periodicals, Inc. (Hide copyright information)Copyright

A once-monthly extended-release formulation of naltrexone (Vivitrol) delivered by intramuscular injection was approved by the FDA on October 12. Vivitrol is indicated for treatment and relapse …

Related articles from newspapers, magazines, journals, and more
Vivitrol FDA Approval Conference Call - Final.
News wire article from: Fair Disclosure Wire April 13, 2006 700+ words
Event Brief of Vivitrol FDA Approval Conference Call - Final.
News wire article from: Fair Disclosure Wire April 13, 2006 700+ words
Approval: naltrexone injectable suspension (Vivitrol).(From the FDA)(Brief...
Magazine article from: Brown University Psychopharmacology Update June 1, 2006 700+ words
Approval: Naltrexone injectable suspension (Vivitrol).(From the FDA)(Brief...
Newspaper article from: The Brown University Geriatric Psychopharmacology Update June 1, 2006 700+ words
Approval: naltrexone extended-release injectable (Vivitrol).(From the...
Newspaper article from: The Brown University Child and Adolescent Psychopharmacology Update June 1, 2006 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily